Wednesday May 27, 2020 09:12

PIVOTAL Press Releases

Huobi China to Play Pivotal Role in Development of BSN IT—07 May 20

China's interest in blockchain technology is about to take its next step as the Blockchain-Based Service Network (BSN) comes into commercial effect on April 25. The aim of this network is to allow companies and software developers to be able to plug into

ERBITUX(R) Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) Heathcare—02 Mar 20

DARMSTADT--2 Mar--PRNewswire/InfoQuest

Approval is for ERBITUX(R)in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHNPivotal Phase III study shows significant improvements with ERBITUX(R)in combination with platinum-based therapy with fluorouracil in response rate, disease progression and survival compared to platinum-based chemotherapy aloneThis marks a meaningful step forward in Merck’s commitment as a global specialty innovator - including bringing innovative medicines to markets with high unmet medical needs

Not intended for UK-based media

Merck, a leading science and technology company, today announced that ERBITUX(R)(cetuximab) has been granted approval by the National Medical Products Administration (NMPA) of China for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) in combination with platinum-based therapy with fluorouracil. Evidence from the pivotal Phase III CHANGE II study, on which the approval is based, shows the efficacy and safety of the EXTREME regimen (ERBITUX(R)+ cisplatin + 5-FU, followed by ERBITUX(R)maintenance) vs platinum-based chemotherapy (cisplatin + 5-FU) alone for first-line treatment in Chinese patients with R/M SCCHN. The data showed that the addition of ERBITUX(R)to platinum-based ch

Robert Walters Thailand Opens New Eastern Seaboard Satellite Office Leading recruitment consultancy General—19 Aug 19

Robert Walters, a specialist professional recruitment consultancy headquartered in London, with regional offices in Southeast Asia, is proud to be linking-up talent and employment opportunities with a newly opened satellite office in Thailand's thriving

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Heathcare—18 Feb 19

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell

The Royal Canadian Mint honours bravery and sacrifice by dedicating its 2019 Proof Silver Dollar to Stcoks—09 Jan 19

With each new year, the Royal Canadian Mint maintains the tradition of issuing an annual silver dollar to commemorate a story of national significance. This year, the Mint is proud to honour Canada's pivotal role in the successful Allied invasion of

Fortinet Positioned Furthest for Completeness of Vision in the Challengers Quadrant of Gartners IT—26 Dec 18

John Maddison, SVP of products and solutions at Fortinet said, "SD-WAN plays a pivotal role in realizing the true benefits of digital transformation, but security is often an afterthought. Fortinet has developed best-of-breed SD-WAN functionality fully

East Tech West conference: innovative Guangzhou plays a pivotal role within China#s Greater Bay General—30 Nov 18

The East Tech West event, a tech conference organized by CNBC and the Administrative Committee of Nansha District, was held in the southern Chinese city of Guangzhou, an important hub within the Guangdong-Hong Kong-Macao Greater Bay Area, from November

wire Tube China 2018 - a Gateway to Tap into the Chinese Wire Tube General—07 Aug 18

As one of the pivotal international wire, cable, tube and pipe industry trade platforms in Asia, the upcoming wire China and Tube China will once again be held in Shanghai, ushering in their 16th year since the debut. After its upgrade in 2016, the

Two Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with Heathcare—05 Jun 18

- Two-year follow-up data on meaningful durable response, overall survival (OS) and progression-free survival (PFS) to be presented in patients with metastatic Merkel cell carcinoma (mMCC), a rare and aggressive type of skin cancer Merck and Pfizer

Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Heathcare—29 Nov 17

- Pivotal Phase III Javelin trial investigating avelumab as third-line treatment for patients with unresectable, recurrent or metastatic gastric cancer did not meet its pre-specified primary endpoint of superior overall survival compared to

First Tom Ford Beauty Store Opens in London General—22 Nov 17

Debuting on November 20, 2017, the first TOM FORD beauty standalone store is the ultimate in luxury beaute, expressed through Tom Ford's singular vision. Located in historic Covent Garden (3 The Market Building) this store is a pivotal moment in the

Winners of Xifu International Gold Wedding Jewellery Design Competition reinvigorate the industry General—01 Nov 17

The Xifu International Gold Wedding Jewellery Design Competition is playing a pivotal role in injecting jewellery designs with modern flair and cross-cultural influences. The 2017 competition is still the talk of the town even though its award ceremony

INSIGHTEC Receives FDA Approval to Initiate Pivotal Study of Exablate Neuro for the Treatment of Heathcare—27 Oct 17

INSIGHTEC, the world leader of MR-guided Focused Ultrasound announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to initiate a pivotal study of the Exablate Neuro for treating dyskinesia symptoms or motor

New UN ESCAP report highlights gender equality is pivotal to achieving sustainable General—21 Sep 17

The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) today released the first report to comprehensively map out the intersections between gender and environment at the levels of household, work, community and policy in

Krungsri and Central Group Join Forces in the Launch of Central The 1 Credit Card and Central The 1 Stcoks—09 Mar 17

Krungsri Group joins hands with Central Group to announce the new pivotal cooperation to extend Krungsri Consumer's role as the main financial service partner of Central Group. The two groups also launch today the new products Central The 1 Credit Card

IMF Executive Board Completes Fourth Review of Armenias Extended Arrangement Stcoks—08 Dec 16

- The Executive Board approved the authorities' request for a modification of the end-December 2016 fiscal balance performance criterion. - Strengthening domestic competition and regulatory reforms are pivotal to creating a more broad-based private

Leading Healthcare IT Organizations Partner to Expand Global Impact Heathcare—22 Nov 16

The Healthcare Information and Management Systems Society (HIMSS) and the College of Health Information Management Executives (CHIME) announced a pivotal agreement to jointly partner on all programs and professional communities outside of North America.

Braeburn Pharmaceuticals and Camurus Announce Positive Top-line Phase 3 Results for Long-acting Heathcare—14 Nov 16

Braeburn Pharmaceuticals and Camurus (NASDAQ STO: CAMX) announce positive top-line results from a pivotal Phase 3 randomized, double-blind, double-dummy, active controlled trial of weekly and monthly injections of buprenorphine (CAM2038) for treatment of

Neurim Pharmaceuticals Announces Positive Top-Line Results from Pivotal Phase III Trial of Heathcare—02 Nov 16

Neurim Pharmaceuticals ("Neurim") announced today top-line results from its NEU_CH_7911 Phase III study. PedPRM met the primary efficacy endpoint demonstrating statistically significant improvement in total sleep time (TST) compared to placebo. In

Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Heathcare—01 Jul 16

- Phase III study shows response rate of 61.1% for patients treated with Erbitux plus FOLFOX - 31% decrease in risk of disease progression and 24% decrease in risk of death was achieved with addition of Erbitux to FOLFOX - First prospective study to

Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who Heathcare—09 Jun 16

Patients from pivotal 24-week phase 3 trial RA-BUILD who entered long-term extension study, RA-BEYOND, demonstrate baricitinib continues to inhibit radiographic progression of structural joint damage over one year Eli Lilly and Company (NYSE: LLY) and

Patient-reported outcomes across phase 3 studies of baricitinib demonstrate statistically Heathcare—09 Jun 16

Pivotal trials show treatment with baricitinib resulted in significant improvements in pain, fatigue and ability to perform daily activities compared to methotrexate – the current standard of care – and adalimumab (Humira(R))* Eli Lilly and

Consumer Health to Play a Pivotal Role in Merck#s Africa Growth Strategy Heathcare—09 Jun 16

- Consumer Health at the forefront of Merck's plans to considerably expand on the African continent over the next five years - 2016 will be an investment year in selected African countries for Merck's Consumer Health business, with a focus on its global


HSBC's unrivalled international network and cross-border business banking expertise has played a pivotal role in helping UK oil company Ophir Energy plc complete a major strategic move into Thailand. The move leveraged HSBC's global cash management

Amadeus to build and foster travel tech startup community in Asia Pacific with Amadeus Lifestyle—08 Dec 15

Amadeus officially launches Amadeus Next to mentor, nurture and partner with travel startups in Asia Pacific Amadeus Next dubbed by Hubba Thailand as "something pivotal for the industry and to startups in the travel technology space" Global travel

Power Sector Pivotal to Inclusive Growth in Zambia Stcoks—11 Dec 15

Following successive years of political stability and strong economic growth, Zambia's growth is expected to fall below 4% in 2015 after years of 6.4% average growth between 2010 and 2014, according to the sixth World Bank Zambia Economic Brief. And in

Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal Phase 3 Study in Heathcare—30 Sep 15

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced positive top-line results of RA-BEGIN, the third Phase 3 study evaluating the safety and efficacy of baricitinib, an investigational medicine for patients with

Pivotal ประกาศปรับเปลี่ยนตำแหน่งผู้บริหาร ทั่วไป—19 Aug 15

ร็อบ มี จะดำรงตำแหน่งซีอีโอแทนพอล มาริทซ์ ขณะที่พอล มาริทซ์ จะดำรงตำแหน่งประธานบริหารของคณะกรรมการบริษัท นอกจากนี้ บริษัทยังประเมินรายได้จาก Pivotal Cloud Foundry ที่สูงเป็นประวัติการณ์ สรุป - ร็อบ มี จะสืบทอดตำแหน่งประธานเจ้าหน้าที่บริหาร (ซีอีโอ) ของ

Pivotal Announces Changes in Executive Leadership and Record Results General—19 Aug 15

- Rob Mee will succeed Paul Maritz as CEO. Paul Maritz will remain on Pivotal's Board of Directors as Executive Chairman. Pivotal announces record Pivotal Cloud Foundry financial results. Summary - Rob Mee will succeed Paul Maritz as Chief Executive